Navigation Links
Embryonic Stem Cell Research Executive Order Places Politics Ahead of Science, Says Michigan Catholic Conference
Date:3/9/2009

LANSING, Mich., March 9 /PRNewswire-USNewswire/ -- Michigan Catholic Conference Vice President for Public Policy Paul A. Long today released the following statement regarding an executive order to be issued by President Obama that permits federal taxpayer funding of embryonic stem cell research:

"President Obama's executive order regrettably places ideology and political posturing ahead of proven scientific therapeutic advancements. There are endless studies and stories of patients who have been treated, even cured of their debilitating condition following stem cell therapies that do not necessitate the destruction of human embryos, yet the president today will sign an executive order that makes every tax-paying American citizen unwittingly complicit in the destruction of human embryos for experimental research.

"In his remarks at the National Prayer Breakfast on February 5, President Obama stated 'There is no God who condones taking the life of an innocent human being. This much we know.' Unfortunately, there is no consistency between this profound statement and today's executive order as destroying human embryos is, in fact, taking the life of an innocent human being."

Michigan Catholic Conference is the official public policy voice of the Catholic Church in this state.


'/>"/>
SOURCE Michigan Catholic Conference
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Leukemia stem cells have more in common with embryonic stem cells than adult stem cells
2. UCI behind worlds first embryonic stem cell study in humans
3. FDA OKs 1st Embryonic Stem Cell Trial
4. Bishops Urge New President to Keep Laws on Conscience Rights, Foreign Aid for Abortion, Embryonic Stem Cell Research
5. Embryonic Stem Cell Research Unethical Waste of Taxpayer Money Says Americans United for Life President
6. New advancements in the use of adult, embryonic stem cells for tissue regeneration
7. Researchers Create Embryonic-Like Stem Cells From Human Testes
8. STEMCELL Technologies Introduces AggreWell™400 for Standardized Embryonic Stem Cell and Induced Pluripotent Stem Cell Research
9. Public funding impacts progress of human embryonic stem cell research
10. Embryonic pathway delivers stem cell traits
11. Embryonic Pathways Induce Stem Cell Traits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical ... be the preferred physical therapy provider for Derby City CrossFit, effective immediately. , ... CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will work ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to compare student test score performance for the 2015-16 school year across Wisconsin’s ... voucher programs. Though it highlights important patterns in student test score performance, the ...
(Date:4/25/2017)... Switzerland (PRWEB) , ... April 25, 2017 , ... ... innovation targets, they rely on contracted partners to help with process innovation in ... of combined drug formulation experience along with state-of-the-art analytical equipment in support of ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to ... of acute or chronic problems, I focus on preventative care with all my patients to ... have any questions, always feel free to contact my office and my trained staff will ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DALLAS , April 19, 2017 /PRNewswire/ ... that the first patients in Nashville ... in the Lower Esophageal Sphincter Stimulation for GERD (LESS ... device designed to provide long-term reflux control by restoring ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)...  New research provides evidence that an old drug may ... study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... disease, the oral drug levodopa has long been considered the ... the disease progresses, the effects of the medication can partially ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
Breaking Medicine Technology: